参考文献/References:
[1] Tabata M,Kadomatsu T,Fukuhara S,et al.Angio-poietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance[J].Cell Metab,2009,10(3):178-188.
[2] Richards J,Gabunia K,Kelemen SE,et al.Interleu-kin-19 increases angiogenesis in ischemic hind limbs by direct effects on both endothelial cells andmacrophage polarization[J].J Mol Cell Cardiol,2015(79):21-31.
[3] Sabat R,Wallace E,Endesfelder S,et al.IL-9 and IL-20:two novel cytokines with importance in inflammatory diseases[J].Expert Opin Ther Targets,2007,11(5):601-612.
[4] Barrett JC,Clayton DG,Concannon P,et al.Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes[J].Nat Genet,2009,41(6):703-707.
[5] Chang CS,Magracheva E,Kozlov S,et al.Crystal structure of interleukin-19 defines a new subfamily of helical cytokines[J].J Biol Chem,2003,278(5):3308-3313.
[6] Cuneo AA,Herrick D,Autieri MV,et al.IL-19 reduces VSMC activation byregulation of mRNA regulatory factor HuR and reduction of mRNA stability[J].J Mol Cell Cardiol,2010,49(4):647-654.
[7] Savasan ZA,Chaiworapongsa T,Romero R,et al.Interleukin-19 in fetal systemic inflammation[J].J Matern Fetal Neonatal Med,2012,25(7):995-1005.
[8] Esposito K,Nappo F,Marfella R,et al.Inflammation cytokine concentrations are acutely increased by hyperglycemia in human:role of oxidative stress[J].Circulation,2002,106(16):2067-2070.
[9] Klover PJ,Zimmers TA,Koniaris LG,et al.Chronic exposure to interleukin-6 casues hepatic insulin resistance in mice[J].Diabetes,2003,52(11):2784-2789.
[10] Jain S,Gabunia K,Kelemen SE,et al.The anti-inflammatory cytokine interleukin 19 is expressed by and angiogenic for human endothelial cells[J].Arterioscler Thromb Vasc Biol,2011,31(1):167-175.
[11] 于正清,李 礼,胡娟玉,等.2型糖尿病患者血清CA199与HbA1c的相关性研究[J].现代检验医学杂志,2013,28(3):114-116.
Yu ZQ,Li L,Hu JU,et al.Correlation between CA199 and HbA1c in patients with type 2 diabetes millitus[J].Journal of Modern Laboratory Medicine,2013,28(3):114-116.
相似文献/References:
[1]余安运,刘夏炎,宋 煜,等.血清脂蛋白(a)和同型半胱氨酸(HCY)
与2型糖尿病胰岛素抵抗的临床研究[J].现代检验医学杂志,2016,31(03):65.[doi:10.3969/j.issn.1671-7414.2016.03.018]
YU An-yun,LIU Xia-yan,SONG Yu,et al.Clinical Study of Serum Lipoprotein(a)
and Homocysteine with Type 2 Diabetes Mellitus and Insulin Resistance[J].Journal of Modern Laboratory Medicine,2016,31(03):65.[doi:10.3969/j.issn.1671-7414.2016.03.018]
[2]王继贵.基质金属蛋白酶和代谢综合征的研究进展[J].现代检验医学杂志,2015,30(03):1.[doi:10.3969/j.issn.1671-7414.2015.03.001]
WANG Ji-gui.Progress of Research on Matrix Metalloproteinases and Metabolic Syndrome[J].Journal of Modern Laboratory Medicine,2015,30(03):1.[doi:10.3969/j.issn.1671-7414.2015.03.001]
[3]李国春a,曹 娜a,王 忆b,等.基础血尿酸水平与糖负荷后胰岛素分泌相关性研究[J].现代检验医学杂志,2015,30(02):105.[doi:10.3969/j.issn.1671-7414.2015.02.032]
LI Guo-chuna,CAO Naa,WANG Yib,et al.Relationship between Concentration of Fasting Uric
Acid and Insulin Secretion after Glycemia Burden[J].Journal of Modern Laboratory Medicine,2015,30(03):105.[doi:10.3969/j.issn.1671-7414.2015.02.032]
[4]李晓燕,李晓华,王养维.幽门螺杆菌感染与2型糖尿病发病机制的相关性探讨[J].现代检验医学杂志,2017,32(01):1.[doi:10.3969/j.issn.1671-7414.2017.01.001]
LI Xiao-yan,LI Xiao-hua,WANG Yang-wei.Helicobacter Pylori Infection and the Pathogeenesis of Type 2Diabetes[J].Journal of Modern Laboratory Medicine,2017,32(03):1.[doi:10.3969/j.issn.1671-7414.2017.01.001]
[5]刘彦君a,梁君蓉b,庞晓宁a.血清趋化素及hs-CRP水平对2型糖尿病患者无症状亚临床动脉粥样硬化诊断的临床意义[J].现代检验医学杂志,2017,32(02):36.[doi:10.3969/j.issn.1671-7414.2017.02.010]
LIU Yan-juna,LIANG Jun-rongb,PANG Xiao-ninga.Clinical Significance of Serum Chemerin and hs-CRP in the Diagnosis
of Subclinical Atherosclerosis in Patients with Type 2 Diabetes[J].Journal of Modern Laboratory Medicine,2017,32(03):36.[doi:10.3969/j.issn.1671-7414.2017.02.010]
[6]刘海龙,张维华,吴晓康.肠道菌群在2型糖尿病发病作用中的研究进展[J].现代检验医学杂志,2017,32(04):157.[doi:10.3969/j.issn.1671-7414.2017.04.045]
LIU Hai-long,ZHANG Wei-hua,WU Xiao-kang.Research Progress on the Function
of Intestinal Flora in Type 2 Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2017,32(03):157.[doi:10.3969/j.issn.1671-7414.2017.04.045]
[7]李 薪,魏力强.2型糖尿病患者血清中脂蛋白相关磷脂酶A2检测的临床意义[J].现代检验医学杂志,2017,32(06):85.[doi:10.3969/j.issn.1671-7414.2017.06.001]
LI Xin,WEI Li-qiang.Clinical Significance of Detection of Lipoprotein Associated
Phospholipase A2 in Serum of Patients with Type 2 Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2017,32(03):85.[doi:10.3969/j.issn.1671-7414.2017.06.001]
[8]张 梅,李林娟,冯旭霞a,等.T2DM并发NAFLD患者血清Nesfatin-1水平变化及相关影响研究[J].现代检验医学杂志,2018,33(01):77.[doi:10.3969/j.issn.1671-7414.2018.01.001]
ZHANG Mei,LI Lin-juan,FENG Xu-xiaa,et al.Analysis of T2DM to the Serum Nesfatin-1 Level Changes
of Patients with NAFLD Horizontal[J].Journal of Modern Laboratory Medicine,2018,33(03):77.[doi:10.3969/j.issn.1671-7414.2018.01.001]
[9]张阳东,周建荣,楚瑞雪,等.PECAM-1基因rs7503550位点多态性和表达水平与冠心病及2型糖尿病的相关性研究[J].现代检验医学杂志,2019,34(03):21.[doi:10.3969/j.issn.1671-7414.2019.03.005]
ZHANG Yang-dong,ZHOU Jian-rong,CHU Rui-xue,et al.Relativity Study on rs7503550 Polymorphism and Genes Expression Levelsof PECAM-1 in Coronary Artery Disease and Type 2 Diabetes Mellitus[J].Journal of Modern Laboratory Medicine,2019,34(03):21.[doi:10.3969/j.issn.1671-7414.2019.03.005]